Reshma Ramlal: Which Donor Characteristic Matters Most in Allogeneic HCT Selection in the PTCy Era?
Photo: moffitt.org

Reshma Ramlal: Which Donor Characteristic Matters Most in Allogeneic HCT Selection in the PTCy Era?

Reshma Ramlal, Associate Member at Moffitt Cancer Center, shared a post on X:

“Test your BMT knowledge

In the era of post-transplant cyclophosphamide (PTCy), which donor characteristic is most important when selecting among otherwise suitable allogeneic HCT donors?

Answer and explanation, and pertinent studies below.”